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Background: High-throughput simultaneous quantitative and qualitative (Quan/Qual) analysis is
attractive to combine targeted with non-targeted analysis, e.g. in pharmacometabolomics and drug
metabolism studies. This study aimed to investigate the possibilities and limitations of high-throughput
Quan/Qual analysis by ultra-high performance liquid chromatography (UHPLC) coupled with high-
resolution mass spectrometry (HRMS), to develop a widely applicable Quan/Qual UHPLC-HRMS
method and to provide recommendations for Quan/Qual method development.
Methods: A widely applicable 4.25-min UHPLC method for small-molecules was used to investigate and
optimize mass spectrometric parameters of a Synapt G2S for Quan/Qual analysis. The method was
applied on a rat metabolomics study investigating the effect of the fasting state and administration of a
dosing vehicle on the rat plasma metabolic proﬁle.
Results: Highly important parameters for high-throughput Quan/Qual analysis were the scan mode and
scan rate. A negative correlation was found between the amount of qualitative information that a method
can provide and its quantitative performance (accuracy, precision, sensitivity, linear dynamic range). The
optimal balance was obtained using the MSE scan mode with a short scan time of 30ms. This 4.25-min
Quan/Qual analysis method enabled quantiﬁcation with accuracy and precision values 20% at the
lowest quality control (QC) level and 15% at higher QC levels for 16 out of 19 tested analytes. It provided
both parent m/z values and fragmentation spectra for compound identiﬁcation with limited loss of
chromatographic resolution and it revealed biologically relevant metabolites in its application to the
metabolomics study.
Conclusion: Quan/Qual method development requires balancing between the amount of qualitative data,
the quality of the quantitative data and the analysis time. Recommendations are provided for MSl (A.-C. Dubbelman).
r B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
A.-C. Dubbelman et al. / Analytica Chimica Acta 1020 (2018) 62e75 63resolution, scan mode, scan rate, smoothing and peak integration in Quan/Qual method development
and analysis.
© 2018 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
High-resolution mass spectrometry (HRMS) has become
increasingly popular over the last decade for use in quantitative
bioanalysis [1]. It offers the possibility to do simultaneous quanti-
tative and qualitative (Quan/Qual) analysis, which is attractive for
studies combining targeted and non-targeted analysis, such as
those investigating the absorption, distribution, metabolism and
excretion (ADME) of a (radiolabeled) drug and pharmacometabo-
lomic studies. Today, Quan/Qual analysis applying HRMS is still
mostly applied in non-regulated early stage drug discovery and
metabolomics. It is expected, however, that its use will expand to
regulated bioanalysis [2], where currently the triple-quadrupole
mass spectrometer (QqQ-MS) still runs the show. In order to
compete with the contemporary short UHPLC-QqQ-MS analysis
methods for large scale studies, a Quan/Qual analysis method needs
to be fast and sensitive, and this represents a challenge for the high
resolution mass spectrometer. Various Quan/Qual methods have
already been published (e.g. Refs. [3,4]), but this work does not only
provide a Quan/Qual method that is widely applicable for targeted
and non-targeted analysis of small molecules, it focuses on the
mass spectrometric challenges encountered when applying Quan/
Qual in a high-throughput fashion and provides recommendations
how to deal with these challenges. In addition, the applicability of
the method is demonstrated in a metabolomics study.
Previously, we evaluated various sub-2 mm particle size ultra-
high performance liquid chromatography (UHPLC) columns and
mobile phases to develop a fast (4.25min) and easy-to-use chro-
matographic methodwith an excellent chromatographic resolution
[5]. In the present study, we aim to evaluate how to optimally use
HRMS to achieve reliable quantiﬁcation and collect qualitative in-
formation applying this chromatographic method, minimizing
compromises to its chromatographic resolution.
Various mass spectrometers of several vendors are being or
could be used for Quan/Qual analysis. Examples are the TripleTOF®
series from Sciex, the Synapt® and Xevo® series from Waters, the
6500 series QTOF LC-MS and 6200 series TOF LC-MS systems from
Agilent Technologies, the LCMS-IT-TOF MS from Shimadzu, the
compact, impact™ and maXis™ series ESI-QTOF Instant Exper-
tise™ mass spectrometers from Bruker and the Q-exactive™ from
Thermo Scientiﬁc, each with their own advantages and limitations
[6]. In the present study, we used the Synapt G2S mass spectrom-
eter (Waters). An advantage of this instrument is the variety of scan
modes, of which TOF-MS, MSE and HDMSE provide an increasing
amount of qualitative information. In the TOF-MS mode, the colli-
sion energy is at a ﬁxed low level in order to detect the parent ions.
In theMSEmode, low and high collision energy scans are alternated
to provide both accurate parent ion masses and data-independent
fragmentation spectra of all ions. In the HDMSE mode, ion mobility
separation is applied, providing an additional dimension of sepa-
ration and an additional identiﬁer of an ion, i.e. the collisional cross
section, which is related to the drift time.
To obtain our goals, ﬁrst theMS resolutionmode and scan rate of
a Synapt G2S mass spectrometer were optimized to accommodate
the high-throughput Quan/Qual analysis. Then the TOF-MS, MSE
and HDMSE scan modes were evaluated for their quantitativeperformance in terms of accuracy, precision, linear dynamic range
and sensitivity, using a test set of 19 small-molecule drugs, selected
for their diversity in molecular masses (151e749 Da), hydropho-
bicity (log P of 0.91e6.7) and pKa values (ranging from an acidic
pKa of 3.77 to a basic pKa of 9.68). The qualitative performance of
theMSE and HDMSEmodewere evaluated based on an in-vitro drug
metabolism study.
An ideal example application of the developed Quan/Qual
analysis method is to simultaneously investigate drug metabolism
and changes in endogenous metabolism related to the drug
administration. The problem in this use is however that in vivo
ADME studies often lack (appropriate) control samples and make
use of generic blank control samples. In this case, drug metabolites
may still be identiﬁed based on radioactivity measurements (in
case of radiolabeled mass balance studies) or fragmentation pat-
terns. However, differences between endogenous metabolite levels
which changed upon drug administration are more complicated to
ﬁnd and may include many false positives that are only related to
e.g. fasting state or to a dosing vehicle. In this perspective, Fiebig
et al. recently recommended the use of control samples of the same
gender and intravenously dosed with the same dosing vehicle, for
ADME studies in rat [7]. Here we demonstrate the applicability of
the Quan/Qual method for metabolomics studies in a similar set-
up, investigating differences in rat plasma metabolome caused by
a dosing vehicle, the fasting state or by bench instability (i.e. short-
term storage at room temperature). The results show that the
developed method is not only fast and widely applicable, but also
capable to provide biologically relevant information.
2. Experimental
2.1. Chemicals
Water was obtained from a Milli-Q Puriﬁcation System from
Millipore (MA, USA). Acetonitrile, methanol (both Ultra LC-MS
grade) and isopropanol (HPLC-MS grade) were supplied by Actu-
All Chemicals (Oss, the Netherlands) and dimethylsulfoxide
(DMSO, 99.7%) and formic acid (ULC-MS grade) by Biosolve
(Valkenswaard, the Netherlands). Ammonium acetate (>99%) and
the drug product standards of acetaminophen, tolbutamide, 19-
norethindrone, omeprazole, prednisone, buspirone hydrochloride,
(þ/)-verapamil hydrochloride, nefazodone hydrochloride and
loperamide hydrochloride originated from Sigma-Aldrich (St. Louis,
MO, USA). Abiraterone was supplied by Cambridge Major Labora-
tories, Inc. (WI, USA). Cilag AG (Schaffhausen, Switzerland) pro-
vided darunavir ethanolate and midazolam was obtained from
Actavis (Dublin, Ireland). Janssen Research and Development
(Beerse, Belgium) supplied the drug product standards of galant-
amine hydrobromide, rilpivirine, risperidone, bedaquiline and
simeprevir. An overview of the physicochemical properties of the
compounds is provided in Supplementary Table 1. The internal
standards acetaminophen-d4, tolbutamide-d9, galantamine-O-
methyl-d3, risperidone-d4, verapamil-d6 hydrochloride and
bedaquiline-d6 (mixture of diastereomers) and the metabolites 10-
hydroxy midazolam and 4-hydroxy midazolamwere obtained from
Toronto Research Chemicals (Toronto, Canada).
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Stock solutions of each drug product (2mgmL1) and internal
standard (0.4mgmL1) were prepared in DMSO except for mid-
azolam, which was purchased as a 5mgmL1 saline solution. For
the optimization of mass spectrometric settings, a 4 mgmL1
mixture of all drug products in DMSO was used and diluted to the
desired concentration with a ﬁnal composition of DMSO:acetoni-
trile:water of 1:6:7 (v/v/v). Working solutions for the calibration
standard (CS) and QC samples were prepared from separate pri-
mary solutions containing 100 mgmL1 of prednisone and dar-
unavir and 50 mgmL1 of the other 17 drug products in DMSO,
which were further diluted in DMSO to the desired concentrations.2.3. Chromatographic conditions
Chromatography was performed using an Acquity UPLC system
(Waters, Milford, MA, USA) equipped with a binary solvent man-
ager, sample manager and column oven. Previously investigated
chromatographic conditions for optimal peak capacity were
applied in this study [5]. Brieﬂy, a Cortecs UPLC C18 column
(50mm 2.1mm,1.6 mm,Waters, Etten-Leur, the Netherlands) was
used, connected to the injection valve with a pre-cut
550 0.127mm Viper tubing with ﬁngertight ﬁtting (Thermo
Fisher Scientiﬁc Inc., Waltham, MA, USA) and to the ion source with
470 0.102mm peek tubing. Volumes of 1 mL were injected using
the partial loop needle overﬁll mode. The weak and strong needle
wash solution consisted of 5% methanol in water and meth-
anol:water:isopropanol:formic acid 40:40:20:0.1 (v/v/v/v), respec-
tively. At 45 C, gradient elution was applied with a ﬂow rate of
0.9mL/min, starting at 99% mobile phase A (10mM ammonium
acetate in water) and 1% mobile phase B (acetonitrile:methanol
80:20 (v/v)) for 0.1min. Subsequently, mobile phase B was
increased to reach 90% at 2.25min, 98% at 2.35min, where it was
kept until 3.25min and subsequently decreased to reach 1% at
3.35min until the end of the run (4.25min).
To reduce carry-over, a shark-tooth shaped gradient was inser-
ted in the washing step between 2.35 and 3.25min, whereby B
changed from 98% at 2.8min to 20% at 2.9min and back to 98% at
3.25min. Additionally, four injection valve switches were pro-
grammed, at 2.65, 2.7, 2.75 and 3.3min.Table 1
Main mass spectrometry settings. The following settings were used in the TOF MS
MS Mode TOF MS
Setting:
Capillary voltage (kV) 0.5
Sampling cone (V) 40
Source offset (V) 50
Cone gas (N2, L/h) 50
Desolvation gas (N2, L/h) 1200
Source temperature (C) 150
Desolvation temperature (C) 600
MS function 1:
Trap CE (eV) 4.0
Transfer CE (eV) 2.0
MS function 2: NA
Trap CE (eV)
Transfer CE (eV)
IMS settings:
Trap DC bias
IMS wave height (V)
Variable wave velocity
MS, mass spectrometry; TOF, Time-of-Flight, MSE, mass spectrometry with fragm
collision energy, IMS: ion mobility separation, DC: direct current.2.4. Mass spectrometry
A Synapt G2S (Waters, Manchester, UK) mass spectrometer was
used with electrospray ionization operating in positive ionization
mode. Leucine-enkephalin (m/z 556.2771, 0.1mgmL1) was used
for lock-mass calibration and continuously infused at 20 mL/min.
Applied settings for each scan mode used are listed in Table 1. The
MS parameters were optimized by both direct infusion and ﬂow
injection analysis of the drug mixture. For ion mobility separation,
the default settings as advised by themanufacturer were used, with
exception of the wave velocity. The wave velocity ramp was set
from 1200m/s to 550m/s, to give the maximum separation be-
tween the smallest and largest molecule in the drugmixturewithin
the 20 to 180 bins of the mobilogram (which is the optimal ion
mobility range to maximize separationwithout experiencing carry-
over from slowly drifting ions to the beginning of the next scan).
Mass Spectrometric and chromatographic data were obtained with
Masslynx software (version 4.1, Waters). Data analysis was per-
formed using Targetlynx, UNIFI (version 1.8, Waters) and Microsoft
Excel (MS Ofﬁce 2010).2.5. Optimization of mass spectrometric analysis settings
2.5.1. Resolution mode
To compare the resolution modes “sensitivity”, “resolution” and
“high resolution”, a 143 ngmL1 solution of the 19 drugs was
injected three times per resolution mode applying the Quan/Qual
LC-TOFMS method with a scan time of 100ms. Peak intensities and
noise levels (after a Savitzky-Golay smoothing factor of two itera-
tions at a window of one scan), chromatographic peak widths at
half maximum of the peak (FWHM, without smoothing) and mass
spectrometric peak widths at FWHM were manually determined
for three compounds: a low mass (acetaminophen, m/z 152.0712),
mid mass (verapamil, m/z 455.291) and high mass (simeprevir, m/z
750.2995) compound. Extraction windows of 0.02 Da around the
measured mass instead of the exact masses were applied for all
resolution modes to avoid differences in calibration accuracies. The
chromatographic peak widths were used to calculate the peak ca-
pacity as 1þ FWHM/gradient time, using the gradient time of 135 s.
The mass spectrometric peak widths were used to calculate the
mass resolution as m/z/FWHM., MSE and HDMSE mode.
MSE HDMSE
0.5 0.5
40 40
50 50
50 50
1200 1200
150 150
600 600
Low energy Low energy
4.0 4.0
2.0 2.0
High energy High energy
15e35 (ramped) 4.0
2.0 15e35 (ramped)
45.0
40.0
1200e550 (ramped)
entation of all ions; HDMSE: High-deﬁnition (ion mobility assisted) MSE; CE:
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To test the effect of the scan time on the Quan/Qual method, a
3.6 ngmL1 and a 36 ngmL1 solution of the 19 drugs was analyzed
in ﬁve-fold applying the Quan/Qual LC-MSE method with each of
the following scan times: 15, 20, 30, 40, 60, 80 and 100ms. The peak
capacity and signal-to-noise ratios were determined using Target-
lynx and the precision was calculated as the coefﬁcient of variation
(%CV) of the peak areas. Various smoothing factors were applied
while monitoring the peak capacity and signal-to-noise ratio and
inspecting the chromatographic peak shape to choose a suitable
smoothing factor.
2.6. Evaluation of scan modes for quantitative analysis
The quantitative performance of the Quan/Qual method was
tested in the TOF-MS mode (with 100ms and 30ms scan time), the
MSE mode (with 30ms scan time) and HDMSE mode (with 86ms
scan time). Two 16-points plasma calibration sets (including a
double blank and single blank) and ﬁve levels of plasma QC samples
were prepared to accommodate the various measurable ranges of
the 19 different compounds. Hereto, human citrate plasma (of a
male volunteer) aliquots of 50 mL were spiked with an appropriate
volume combination of a CS or QC working solution and DMSO to
obtain a ﬁnal volume of 90 mL. A 10 mL volume of internal standard
mixture in DMSO (containing 1.5 mgmL1 of acetaminophen-d4,
tolbutamide-d9 and bedaquiline-d6, 150 ngmL1 of galantamine-
O-methyl-d3 and 300 ngmL1 of risperidone-d4 and verapamil-
d6) was added to all samples except the double blank. The CS
samples contained 0, 0.5, 1, 2, 4, 5, 10, 20, 40, 50, 100, 200, 300, 450
and 500 ngmL1 and the QC samples 1, 2, 20, 100 and 450 ngmL1
of each drug in plasma, and twice as much for prednisone and
darunavir. The 100 mL volumes were vortex mixed (1min) with
150 mL of acetonitrile and centrifuged (5min, 4 C, 13600 g). Sub-
sequently, 200 mL of the supernatant was transferred to a clean
tube, vortex mixed (1min) with 150 mL of water and analyzed.
After LC-MS analysis of the samples, TargetLynx was used for 2D
peak integration of the data in all four data sets and UNIFI was used
for 2D and 3D peak integration of the data collected in HDMSE
mode. Lists with peak responses were exported to Excel for further
calculations.
An internal standard was chosen for each analyte using the QC
samples. Hereto, the CV% of the QC samples was calculated for the
peak responses of each analyte, as well as for the peak response
ratio with each of the deuterated internal standards. The internal
standard giving the smallest variation was selected or no internal
standard correction was applied if variation was better without IS.
Log/log transformationwas applied and linear calibration curves
were constructed in Excel by excluding calibration points with a
signal-to-noise ratio below 5 or a relative error of more than 20%
from the curve. Additionally, if the precision (the CV% of the
calculated concentrations) of a QC level exceeded 20%, all calibra-
tion levels up to this point were excluded. A calibration curve was
accepted only if minimally 6 non-zero calibration levels were
included and no more than 25% of the calibration points (>LLOQ)
were excluded. QC samples with a peak area ratio more than 1.5
interquartile ranges below the ﬁrst quartile or above the third
quartile were marked as an outlier [8] and excluded in the calcu-
lation of the accuracy and precision of the affected compound. To
compare the sensitivity between modes, a detection limit was
calculated as 3 times the standard deviation of the lowest QC level.
2.7. Evaluation of scan modes for drug metabolite analysis
The qualitative performance of the MSE and HDMSE scan modes
was evaluated using incubation samples of rat hepatocytes withbuspirone. The hepatocytes were treated as described previously
[5] and cell suspensions containing 1.0 106 cells mL1 were
incubated with buspirone at a concentration of 5 mM. Aliquots were
taken at t¼ 0min (control) and at t¼ 120min and immediately
stored at 20 C until analysis. The incubation samples were
precipitated with three volumes of acetonitrile, centrifuged for
5min at 3000 g and the supernatants were injected on the column.
Data analysis was performed in UNIFI. Separate metabolite
identiﬁcation analysis methods were made for the MSE and the
HDMSE data, but settings were kept the same as much as possible.
The 2D peaks were smoothed (Savitsky Golay, half width 1 and 2
iterations). The MSE method searched for 3D peaks (m/z, RT, in-
tensity) and the HDMSE method for 4D peaks (m/z, RT, intensity,
drift time), both with a maximum of 100000 peaks per channel.
Buspirone was added as expected component, a wide selection of
common phase I and phase II transformations was included and the
dealkylation tool [9] was activated. Targeted screening was based
on retention time (0.1min tolerance, burspirone only) and mass
(20 ppm tolerance, all potential metabolites based on phase I and
phase II transformations). Binary comparisonwas performedwith a
mass tolerance of 5 ppm and retention time tolerance of 0.05min.
To clean the obtained peak lists, features with any of the following
characteristics were ﬁltered out: only found in the t¼ 0 h sample,
not tentatively identiﬁed by the software, eluting outside the
retention time window of 0.2e2min (unchanged buspirone eluted
at 1.43), having an intensity< 0.5% of the parent, having< 2 iden-
tiﬁed high energy fragments, having identiﬁcation anomalies and/
or being< 2.5  as intense in the 120-min sample as in the 0-h
sample.
2.8. Application of the Quan/Qual method to a non-targeted study
The Quan/Qual UHPLC-MSE method was applied to explore the
effect of a dosing vehicle on the metabolite proﬁle of a rat. The
study procedures were covered by and in conformance with the
animal Health regulation of Jansen Pharmaceutica, Beerse, Belgium.
Six groups of three Sprague Dawley rats were included. Three of the
groups had fasted for 12 h, the other three groups received a
standard diet. Of both the fasted and the fed rats, three received a
single oral dose of 10mL kg1 PEG400, three an empty cyclodextrin
(20%) vehicle and three were used as a control. One blood sample
was collected per rat, 4 h after vehicle administration, and centri-
fuged to obtain plasma samples. The plasma samples were stored
at 20 C and transported to the Leiden Academic Center for Drug
Research. Duplicate 50 mL aliquots of individual samples were
prepared, as well as QC pools, comprising equal volumes of each
plasma sample. Sample preparationwas performed as described for
plasma in section 2.6, whereby the internal standard mixture and a
CS working solutionwas spiked to obtain a plasma concentration of
100 ngmL1 of the drug mixture. The QC samples were analyzed in
triplicate at the start, middle and end of the analytical run and the
individual samples were randomized in-between.
Targeted data analysis for QC was performed using Targetlynx
and non-targeted feature detection using Progenesis QI (Nonlinear
Dynamics, Newcastle, United Kingdom). The feature detection list
from all samples was exported to Excel and ﬁltered: features with a
chromatographic peakwidth<0.01min, with a CV%> 30% in the QC
samples and a retention time outside 0.2e1.51min were excluded
to minimize the number of false positive peaks. statistical analysis
which was performed using MetaboAnalyst 3.0 [10], whereby the
samples from PEG-dosed rats and the QC samples were excluded
because of too much matrix effect. For the data analysis, zero or
missing values were replaced with a small value (half of the min-
imum positive value in the original data). To make features more
comparable, the data was transformed using log normalization and
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using Analysis of Variance (ANOVA). Only features with a p-value <
0.05 were used to construct a principal component analysis (PCA)
plot and to determine the most discriminative features between
the groups based on their variable importance in projection (VIP)
score.
3. Results and discussion
3.1. Optimization of mass spectrometric analysis settings
Important characteristics of an MS method for high-throughput
Quan/Qual workﬂow are sensitivity, chromatographic peak capac-
ity and mass resolution. Additionally, a practical consideration is
the ﬁle size.
3.1.1. MS resolution
The sensitivity, mass resolution and ﬁle size were ﬁrst tested in
the three available resolution modes on the Synapt G2S: the
sensitivity mode, the (normal) resolution mode and the high-
resolution mode. When the instrument operates in the sensitivity
mode or resolution mode, the ions in the TOF section are reﬂected
once (also referred to as V-mode) before reaching the detector. In
the high-resolution mode, ions are reﬂected three times, following
a W-shaped path. The increase in ﬂight time in this mode com-
pensates for the distribution in kinetic energy within the ion
packages, resulting in an increase of the mass resolution, however
at a cost of sensitivity [11].
In the resolution mode, the 143 ngmL1 academic solution of a
low-, mid- and high-mass compound gave a median peak intensity
of 1.18*106, a signal-to-noise ratio of 1.0*104 and a mass resolution
of 25 k. The mean ﬁle size was 1.69 Gb. Supplementary Fig. 1 dis-
plays the relative differences of the sensitivity mode and the high
resolution mode with respect to these values in the resolution
mode.
The high resolution mode was characterized by a severely
reduced sensitivity, with median peak intensities and S/N being
around 300 and 14 times lower, respectively, than in the normal
resolution mode. As a logical result, the high resolution mode gave
the smallest ﬁle size (the number of detected ions is smaller).
Despite this advantage, the low absolute peak intensities will
hamper the detectability of low concentration compounds, making
this mode less suitable for Quan/Qual analysis, especially when low
exposure concentrations are expected.
No big differences were observed between the sensitivity mode
and the resolution mode. Even though the peak intensity in the
sensitivity mode was around 1.6 times the intensity in the resolu-
tion mode, the S/N was 14% lower. This can most probably be
attributed to the high concentration test sample used. This allowed
the comparison of the 3 resolution modes with the same sample,
but resulted in detector saturation for some compounds in the
sensitivity mode. Consequently, at lower compound concentrations
the S/N difference between the sensitivity mode and the resolution
mode may be in favor of the ﬁrst. The mass resolution was very
similar instead of the expected two-fold difference, but this highly
depends on the tuning condition of the instrument. The ﬁle size
was largest in the sensitivity mode, as this ﬁle is the richest in data
points. It was observed (not shown here) that the difference in ﬁle
size between the resolution modes becomes much more pro-
nounced upon injection of a matrix sample instead of an academic
standard, as can be expected since all matrix ions are also included.
Considering the wide applicability we aim for Quan/Qual analysis
and the similar performance of the modes in this case, but the
potential lower mass resolution of the sensitivity mode on other
instruments, the (normal) resolution modewas considered optimalfor the Quan/Qual workﬂow and used in further experiments.
3.1.2. Scan time and smoothing
Another important MS parameter in high-throughput Quan/
Qual analysis is the data acquisition rate or the scan time. If the scan
time is too long, the chromatographic peak contains too few data
points to describe its shape, compromising both the precision
(invaluable in quantitative analysis) and the chromatographic res-
olution (essential for qualitative analysis) [12,13]. On the other
hand, a short scan time can introduce more variability and can
compromise the sensitivity, because less transients can be accu-
mulated per scan, resulting in a spectrum with a lower signal-to-
noise ratio [14].
Fig. 1 shows the practical consequences of these theoretical scan
time effects on the Quan/Qual UHPLC method. Panel A displays the
median of the peak area precision (n¼ 5) over the 19 analytes per
scan time and shows no clear correlation between the two at the
evaluated concentration level. In contrast, increasing the scan time
had a detrimental effect on the chromatographic peak resolution,
as shown in panel B. The chromatographic resolution (expressed as
peak capacity) almost linearly decreased with scan time making it
increasingly difﬁcult to separate close-eluting isomers with the
Quan/Qual method. The sensitivity, on the other hand, expressed as
the median signal-to-noise ratio and plotted against the scan time
in panel C, increased signiﬁcantly at the start but seemed to reach a
plateau around 60ms. The optimal balance between the chro-
matographic resolution and sensitivity was achieved with a scan
time from 30ms to 60ms, as the loss in resolution and sensitivity
compared to their maximum values was minimal for these values,
independent of the sample concentration. A scan time of 30ms was
selected for further experiments in TOF-MS and MSE mode.
If the Synapt G2S operates in a scan mode employing IMS, the
minimal scan time is 86ms. Therefore, the effect of higher scan
times (86mse300ms) was tested in the HDMSE mode. This
resulted in a further decrease of the peak capacity to only 83 at a
scan time of 300ms, while the effect on the sensitivity remained
marginal (S/N of 500 at a scan time of 86ms increased to around
750 at scan times of 125ms up to 300ms) and still no trend was
observed in the precision of the peak areas, suggesting that in
HDMSE mode the minimal scan time of 86ms is optimal for high-
throughput UPLC separation.
In general, the scan times for the Synapt G2S advised by the
manufacturer are larger than the applied 30ms in MSE mode and
especially the 86ms in HDMSE mode. Each IMS experiment re-
quires 200 pushes and the TOF-pusher interval at a mass range of
m/z 50e1200 is 54 ms, resulting in an IMS duty cycle time of 10.8ms.
With a scan time of 86ms, and alternating low and high collision
energy (MSE), only four IMS experiments can be combined into one
scan. To check the effect of this low number on the variability in the
mobilogram, the precision of the drift times of the QC samples used
for the quantitative analysis was calculated. Generally, the CV% was
around 0.3% (results not shown), so very precise. Only for com-
pounds displaying severe detector saturation as a broad and ﬂat-
tened peak in the mobilogram, the CV% was higher due to the high-
concentration samples and in the order of 1.5%.
Not only the scan time, but also the smoothing factor is
important for chromatographic resolution, as illustrated in Fig. 2.
This ﬁgure shows extracted ion chromatograms of rilpivirine,
which has an E and Z isomer that can chromatographically be
separated. The panels A to C have increasing scan times of 30ms,
86ms and 200ms, and panels D, E and F show the same data after a
Savitzky-Golay smoothing factor of two iterations at a window of
one scan. This example illustrates that use of a scan time of 200ms
and smoothing (panel F) can severely compromise a carefully
optimized chromatographic resolution.
Fig. 1. Effect of the mass spectrometric (MS) scan time on precision, peak capacity and signal-to-noise ratio. Effect of the MS scan time on the mean precision (A), median
chromatographic peak capacity (B) and median signal-to-noise ratio (C). Values are calculated over 19 compounds measured in 5-fold per scan time, applying an MSE scan protocol
in (normal) resolution mode and a Savitzky-Golay smoothing factor of two iterations over a single data point window.
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Fig. 2. Effect of the mass spectrometric scan time and smoothing on the separation of close-eluting isomers. Extracted ion chromatogram of rilpivirine E and Z isomers,
measured with different scan times, before (upper panel) and after (lower panel) application of a Savitzky-Golay smoothing factor of two iterations over a single data point window.
The scan time increases from left to right from 30ms (A,D) to 86ms (B,E) and 200ms (C,F).
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out the noise: in general we observed that application of even the
smallest possible smoothing factor resulted in a lower peak in-
tensity, but roughly in a two-fold increase of the sensitivity in terms
of signal-to-noise ratio. The amount of smoothing that is adequate
for a chromatographic separation is related to the number of data
points per peak. In Fig. 2 panel A, B and C, the main peak (above 10%
of the peak height) contains 11, 7 and 4 data points, respectively,
explaining the difference in appearance after smoothing in D, E, and
F. Of note, even though it is common practice to use 15e20 data
points per peak, the next section demonstrates that also these
sparsely described peaks (with 11, even down to 7 points) can give
acceptable quantitative results. To make this even more visible, the
precision of the peak area of rilpivirine is plotted against the
number of data points across the peak in Supplementary Fig. 2.
Although this shows a general trend of decreasing CVs with anincreasing number of data points per peak, it also shows that even
with the scan time of 100ms, which gave only 4 data points on the
peak at a concentration of 36 ngmL1, the CV of the peak area is
only 4.9%. The good precision of sparsely described peaks was also
observed by Henry et al. when they compared an OrbitrapMS and a
QqQ MS for quantitative analysis [15].
Both the smoothing window and the number of iterations were
optimized. Increasing the window generally resulted in broadening
of the peak with limited additional improvement of the signal-to-
noise ratio. Also the effect of increasing the number of iterations
on the signal-to-noise ratio was small, but it did improve the
ﬂuency of the peak shape. A Savitzky-Golay smoothing factor of
two iterations at a window of one scan was considered optimal for
the Quan/Qual method, based on manual inspection of the peaks
and comparison of the chromatographic resolution.
A.-C. Dubbelman et al. / Analytica Chimica Acta 1020 (2018) 62e75683.2. Evaluation of scan modes for quantitative analysis
Themass protocols TOF-MS,MSE and HDMSEwere compared for
their quantitative performance. In the TOF-MS mode a scan time of
both 30ms and 100ms was tested to investigate whether the
quantitation is compromised by the short scan time. The resultingFig. 3. Experimental linear dynamic ranges and calculated limits of detection (LoDs) in
of the 19 test compounds for each of the analysis modes. A striped bar indicates that one or
asterisks indicate the theoretical LoDs (due to their calculation as 3 times the standard devia
the tested dynamic range, this theoretical value can be too high in cases where the lowest
colour in this ﬁgure legend, the reader is referred to the Web version of this article.)linear ranges and theoretical detection limits are visualized in Fig. 3
and the accuracies and precisions in Fig. 4. Before actually
comparing these results from the different modes, we will shortly
discuss the methods applied to obtain them.
First, the acceptance criteria: for a Quan/Qual workﬂow to be
adopted on a regular basis in pharmaceutical research andvarious mass spectrometric modes. The green bars show the linear calibration ranges
more QC levels within the linear range have an accuracy deviating more than 20%. The
tion of the lowest accepted QC level and the availability of only 5 QC levels throughout
QC level(s) were outside acceptance criteria). (For interpretation of the references to
Fig. 4. Accuracy and precision per QC level in various mass spectrometric modes. The radar plots on the left visualize per QC level the accuracies (n¼ 5, absolute deviations) of
the 19 test compounds for each of the MS protocols. Data points within the ﬁrst green ring have a high accuracy (<15% deviation) and data points in the outer red ring have a low
accuracy (>20% deviation). The radar plots on the right visualize the precision (n¼ 5) of the 19 test compounds for each analysis mode. Only QC levels within the calibration range
are included. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
A.-C. Dubbelman et al. / Analytica Chimica Acta 1020 (2018) 62e75 69development, the quantitative capacity should be comparable to
traditional quantitative bioanalytical assays. In non-regulatory
exploratory bioanalysis, acceptance criteria of 20%e25% for cali-
bration points, accuracy and precision are commonly applied. In a
regulated setting, more strict criteria of 15% and 20% at LLoQ levelare prescribed in the FDA guidelines for Bioanalytical assay vali-
dation [16]. In the current study, we ﬁxed the acceptance criteria to
20% at all concentration levels to demonstrate the differences in
performance of the tested quantitative MS modes.
Second, the use of internal standards: for quantitative drug
A.-C. Dubbelman et al. / Analytica Chimica Acta 1020 (2018) 62e7570analysis it is widely agreed that the use of a stable isotope labeled IS
for each analyte to be quantiﬁed is preferred over any other type of
standardization [17]. However, these are often not available in early
drug discovery, so we selected a set of internal standards (stable
isotopes of drugs in the standard set) covering a wide chemical
space. Each analyte was matched with the internal standard giving
the best precision of the peak response ratios in the QC samples.
Generally, the differences in precision between the internal stan-
dards were very small, except for the bedaquiline-d6 isomers A and
B, which showed high variability in peak response and did not
improve the precision as an internal standard for any compound
but bedaquiline. This could be explained by the observation of se-
vere matrix effect at the retention time of bedaquiline (2.57min)
due to co-elution of phospholipids and indicates that a stable
isotope IS indeed compensates for this matrix effect. For most other
analytes a good precision was even obtained without internal
standard correction, supporting that the used sample preparation
method is repeatable.
Third, the HDMSE data analysis: the quantitative data included
in Figs. 3 and 4 were analysed using Targetlynx software, which
only uses the retention time, intensity and m/z value for 2D peak
integration, ignoring the ionmobility data. The software UNIFI does
offer possibilities to quantify peaks taking into account the ion
mobility data, using 3D or 4D peak detection and 2D or 3D peak
integration (see Supplementary Fig. 3). The use of the additional
degree of separation for quantitative analysis can be useful for
compounds with common masses, e.g. of endogenous metabolites
withmany (possibly co-eluting) isomers. In addition, using 4D peak
detection, the exact top of a peak can be foundmore accurately, and
quantiﬁcation is therefore expected to give a more precise result
than when using pre-set windows for m/z, retention time and drift
time. The three quantiﬁcation methods were tested for the current
targeted analysis, but showed similar accuracy and precision
values. The potential beneﬁts of using the drift time did in this case
not outweigh the short processing times and user-friendliness of
Targetlynx as compared to UNIFI.
Comparing the four scan protocols in Figs. 3 and 4, it was
observed that they have comparable detection limits, with some
outliers with a high detection limit in the HDMSE mode. As ex-
pected from Fig. 1C, the difference in sensitivity between the scan
time of 30ms and 100ms is marginal. The accuracy and precision of
the lowest CS and QC levels were however for some compounds
affected by carry-over, which resulted in an apparent low sensi-
tivity/high LOD/LOQ for many compounds as compared to litera-
ture data of compound-speciﬁc LC-QqQMSmethods. An example is
galantamine, for which, irrespective of the Synapt G2S scan pro-
tocol, the linear range started at 2 ngmL1, while others reported
an LLoQ of 0.12 ngmL1 for galantamine in (rat) plasma using QqQ
MS [18]. At 1 ngmL1 galantamine could already be detected, but
the carry-over induced variation was too high. Attempts to
decrease the carry-over by including the additional sharktooth-
shaped gradient in the cleaning phase of the chromatogram and
additional switches of the injection valve only partially solved the
problem. Since themain cause appeared to be in the autosampler, it
is expected that the carry-over would be less of a problem (and
even lower concentrations could be quantiﬁed) if a UHPLC-system
with a ﬂow-through needle would be used [19].
All accuracy and precision values are tabulated in
Supplementary Table 2 and Supplementary Table 3, respectively.
The TOF-MS mode with a scan time of 100ms was most accurate
with a median accuracy level (absolute deviation) of 4% (see Fig. 4)
and most precise with a median coefﬁcient of variation of 3% (only
for 2 compounds >15%, at the lowest QC level of 1 ngmL1). These
values are in the range of what is expected from a quantitative
bioanalytical assay from the FDA guidelines [16], demonstrating thequantitative applicability of this Quan/Qual method for a wide
range of compounds, as represented by the 19 test compounds. A
scan time of 30ms gave a similar precision (median of 4%) as the
scan time of 100ms, but was less accurate (the absolute deviation
had a median of 7% and exceeded 20% for 5 compounds at the
lowest QC level).
To increase the amount of qualitative data, other MS protocols
can be used, but as Figs. 3 and 4 implicate, this comes at the cost of a
reduced quantitative performance. The performance of the MSE
mode is almost as good as the TOF-MS mode, with accuracy and
precision values 20% at the lowest QC level and 15% at the
higher QC levels for all analytes except norethindrone, abiraterone
and rilpivirine. The HDMSE mode gives less accurate results and a
smaller linear dynamic range (up to 1 order of magnitude) than the
other modes. This can be explained by the ions focusing in the
helium cell and the ion mobility cell before they enter the TOF
section, thereby more easily leading to saturation of the detector.
Especially for non-targeted analysis, this limited dynamic range can
be a problem. The Masslynx software does offer solutions to
enhance the dynamic range, whereby alternately all ions or only a
part of them reach the detector, but this halves the number of data
points. For targeted analysis, a post-acquisition possibility to
overcome problems with detector saturation is using less abundant
natural isotopes for quantitative analysis [20].
An advantage of the MSE and HDMSE modes over the TOF-MS
mode is that they can give additional speciﬁcity. Although not
tested in this investigation, quantiﬁcation can be performed on the
product ion of a targeted compound, which is collected in the high
energy trace.
3.3. Evaluation of scan modes for drug metabolite analysis
The two most important aspects of a qualitative LC-MS method
are (i) the number of compounds (peaks) that can be detected and
(ii) the amount of structural information that is collected for these
compounds. From the MS scan modes available on the Synapt G2S
it is theoretically the HDMSE mode that would score best on these
aspects. This mode gives an additional dimension in separation (ion
mobility), allowing more peaks to be discovered (e.g. by separation
of coeluting isomers). Additionally, it gives the collisional cross
section (which can be calculated from the drift time) as an addi-
tional feature of the detected compound, next to the accurate mass
of both parent and fragment ions.
For a Quan/Qual workﬂow, however, the applied MS protocol
should perform well in both quantitative and qualitative analysis
and, as demonstrated in the previous section, the HDMSE mode has
some disadvantages in quantitative analysis, e.g. a shorter dynamic
range, and a lower accuracy and precision compared to the TOF-MS
and MSE modes. Since the TOF-MS mode has the clear qualitative
limitation of only providing the parent mass, here only the MSE and
HDMSE mode were evaluated.
Binary comparison of the 120-min and 0-min buspirone incu-
bated rat hepatocyte samples with UNIFI resulted in a peak list of
19590 features found in the MSE mode and 11967 features in the
HDMSE mode. Filtering these lists is required to look at the more
relevant metabolites of buspirone and to eliminate false positives.
After ﬁltering, only 54 features were left on the MSE list and 204 on
the HDMSE list. An additional useful ﬁlter would be to remove all
tentatively identiﬁed features with a mass error >5 ppm. This
would leave 36 compounds on the MSE list and 79 on that of
HDMSE, but due to inaccurate mass detection of some compounds
(possibly related to their high abundance and detector saturation)
in HDMSE mode this led to false negatives. Although the number of
tentatively identiﬁed metabolites was in favor of the HDMSE mode,
a closer look at the tentative identities, chromatograms and spectra
A.-C. Dubbelman et al. / Analytica Chimica Acta 1020 (2018) 62e75 71learned that on the MSE peak list relatively many more compounds
were likely to be real metabolites than on the HDMSE peak list.
Therefore, it may be better to evaluate the two modes based upon
some examples than on the numbers only.
As a ﬁrst example we show the extracted ion chromatogram of
m/z 418.2454, corresponding to buspirone þ 2O, without smooth-
ing (Fig. 5A). In the MSE chromatogram,13 peaks of buspironeþ 2O
isomers can be distinguished; in the HDMSE chromatogram two of
the isomers are combined into one peak due to the low number of
data points on the peak. This phenomenon gets worse when
smoothing is applied as shown in Fig. 5B, wherein only 10 or 11
metabolites seem to be left, as opposed to still 13 in the smoothed
MSE chromatogram. Looking at the ion mobility separation of the
HDMSE analysis, Fig. 5C, the peaks are again all distinguishable and
even the detection of an additional 14th peak in the squared section
may be argued. The difference in drift time between the metabo-
lites is in this case that small that the additional structural infor-
mation in the HDMSE mode will be limited to non-existent.
Altogether, the qualitative information that can be obtained with
MSE is in this example very similar to that with HDMSE.
Amore pronounced difference in ionmobility was found for two
isomeric glucuronic acid conjugates of buspirone in a secondA D
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Fig. 5. Effect of mass spectrometric mode and settings on real-life samples. Extrac
buspirone þ O þ Glucuronide (m/z 578.2826, panel D, E and F) in a rat hepatocyte sample af
shows the raw chromatograms, panels B and E the chromatograms with a Savitzky-Golay s
mobility plot. The arrows indicate the distinguishable peaks.example. Here, it was observed again that the two peaks that can be
distinguished in the non-smoothed EICs collected in MSE mode and
HDMSE mode melted into one peak after smoothing in the HDMSE
mode (see Fig. 5D and E). In the ion mobility plot (Fig. 5F) the two
peaks are however clearly resolved and, although not further
investigated for this study, the experimental collisional cross sec-
tionmay help in their structural identiﬁcation. However, in practice
it is pretty difﬁcult to elucidate metabolites based on their colli-
sional cross section unless applied in a relative mode [21] and IMS
is more often applied for its additional dimension in separation and
conﬁrmation of identity as opposed to structural elucidation.
These two examples show that due to the high degree of sep-
aration obtained in the chromatographic method, the qualitative
advantage of the additional orthogonal separation in HDMSE
analysis is limited for this Quan/Qual method. Additionally, they
stress the importance of critically controlling and evaluating the
effect of data smoothing in qualitative analysis.
3.4. Application of the Quan/Qual method to a non-targeted study
3.4.1. Quality control (Quan)
The Quan/Qual UHPLC-MSE method was used to explore the 
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ted ion chromatograms of buspirone þ O2 (m/z 418.2454, panel A, B and C) and
ter 120min incubation with buspirone, collected with MSE and HDMSE. Panels A and D
moothing factor of two iterations at a window of one scan and panels C and F the ion
A.-C. Dubbelman et al. / Analytica Chimica Acta 1020 (2018) 62e7572effect of a dosing vehicle on the metabolite proﬁle of a rat. Targeted
analysis using Targetlynx was applied to assess the quality of the
measurements. The precision (%CV) of the 19 drugs across the 9
pooled QC samples was between 4% and 14%, except for bedaquiline
which had a precision of 30%. As observed before, the variability at
this point in the chromatogram is more severe, probably due to co-
elution with matrix interferences.
When calculated across all 27 samples (18 study samples and 9
QC samples), the precision of the spiked analytes varied between
12% for tolbutamide and 104% for bedaquiline. It appeared that
acetaminophen and galantamine had systematically lower peak
areas in the sample groups of PEG-dosed rats than in the other
groups. For acetaminophen this is shown in the upper pane of Fig. 6.
Herein, the open dots represent the relative peak area as compared
to the mean peak area of acetaminophen and they are systemati-
cally lower for the PEG-dosed rat groups. Further investigation of
the chromatogram and spectra at the retention time of acetamin-
ophen (0.49min) and galantamine (0.7min) learned that several
high-intensity PEG polymer chains coelute in this area and aremost
probably responsible for this major ion suppression. Therefore, also
the precision was calculated excluding all samples containing
plasma of PEG-dosed rats (i.e. also the QC sample pools). This
resulted in acceptable (<30%) precision for the 12 compounds
eluting up to 1.51min (midazolam), except for darunavir. Darunavir
had a precision of 53% even though it eluted at 1.47min, but this
can be attributed to the overall very low response that was
observed for this compound. The 7 compounds eluting after mid-
azolam suffered frommorematrix effect-related variability and had
precisions up to 97% (for bedaquiline without IS compensation).
To investigate if reliable quantiﬁcation of these later-eluting
compounds is still possible, the stable-isotope labeled internal
standards of verapamil and bedaquiline were used to calculate the
precision of the analyte e internal standard peak area ratio. Across
all 27 samples this resulted in an improvement of the precision of
verapamil from 50% to 10% and bedaquiline from 104% to 10%,
indicating that reliable quantiﬁcation is indeed possible in this re-
gion of the chromatogram if a(n) (stable-isotope labeled) internal
standard is applied. Remarkably, the signal of acetaminophen and
galantamine was so much suppressed in the PEG-dosed rat plasma
samples, that even their stable-isotope labeled internal standardsFig. 6. Quality control of the Quan/Qual analysis method in a non-targeted
application. Quantitative analysis results of two representative spiked analytes after
applying the Quan/Qual method in a metabolomics study exploring the effect of a
dosing vehicle and fasting state on the rat endogenous metabolic proﬁle. The dots
represent the peak area of the spiked analyte compared to the average peak area of
that analyte, whereby no internal standard correction is applied for the open dots ()
and stable isotope labeled internal standard correction is applied for the black dots ().could not completely correct for this, as can be seen from the black
dots in the upper pane of Fig. 6. The lower pane of Fig. 6 shows an
example of a compound (risperidone) eluting between the region
disturbed by PEG and the region where other endogenous matrix
constituents cause signal variability. Even without any correction
the peak area deviation from the mean is within 20% for most
samples and after correction with the stable isotope internal
standard both accuracy and precision improve.
Although in this situation the use of HDMSE instead ofMSE could
be applied to clean fragmentation spectra from co-eluting PEG-
related fragments [22], its use would not solve the ion suppression,
which is a process taking place in the ion-source.
3.4.2. Exploratory non-targeted analysis (Qual)
Exploratory non-targeted analysis was performed on rat plasma
samples, aiming to investigate if the fasting state and the use of a
dosing vehicle inﬂuence the rat metabolomic proﬁle and whether
the Quan/Qual method is capable to provide biologically relevant
information. Profound statistical analysis or biological interpreta-
tion is beyond the scope of this paper.
Based on the quality control and in order to minimize the
number of false positive features that discriminate between the
groups it was decided to exclude the PEG-dosed rat plasma samples
and only analyze the chromatographic window of 0.2e1.51min.
This means that 4 groups with 3 biological replicates were included
in the analysis. An alternative approach would be to include the
PEG dosed rat plasma samples and analyze only the window be-
tween 0.7 and 1.51min. Fig. 7 shows the resulting PCA plot of the
features with a p-value < 0.05 (144 of the original 1996 features)
based on one-way ANOVA. There is a clear distinction between the
four groups, suggesting that indeed features are inﬂuenced by
fasting state and/or by the administration of cyclodextrin as a
dosing vehicle. The ﬁve most important discriminative features
identiﬁed by PLS-DA (see Table 2) differed signiﬁcantly between
the fasted and fed rats, and were upregulated in the fasted rat. A
comparison of their m/z values against the Scripps Center for
Metabolomics database revealed potential identities for three of
them, all acylcarnitines. This would be in line with previous liter-
ature, wherein acylcarnitines were reported as plasma biomarkers
of fed versus fasted rats, being most abundant in fasted rats [23].
The separation in the metabolic proﬁle observed in Fig. 7 be-
tween both fasting state and administration of cyclodextrin war-
rants the selection of not only fasting state-matched, but also
dosing vehicle-matched blank samples in for example pharmaco-
metabolomic studies. Obviously, more information could be
extracted from this data, e.g. by comparing only two groups
simultaneously, but already this example clearly demonstrates the
applicability of the Quan/Qual method in a non-targeted metab-
olomics study.
4. Conclusions
Quan/Qual method development requires balancing between
the amount of qualitative data, the quality of the quantitative data
and the analysis time. In this study, we investigated the effect of the
mass resolution, scan mode, scan rate, smoothing, and peak inte-
gration in Quan/Qual method development and analysis, using a
4.25min widely-applicable UHPLC chromatography. Based on the
results it is proposed that the optimal balance can be obtained
using the normal resolution mode with MSE analysis, a scan time of
30ms, and a Savitzky-Golay smoothing factor of two iterations at a
window of one scan. In a targeted quantitative application,
applying 2D peak integration in Targetlynx software, these settings
enabled quantiﬁcation with accuracy and precision values 20% at
the lowest QC level and 15% at higher QC levels for 16 out of 19
Fig. 7. Example of results of the Quan/Qual analysis method in a non-targeted application. Principal component analysis plot of the features with an ANOVA p-value > 0.05
upon comparison between plasma samples of fasted and fed (standard diet) rats, dosed with cyclodextrin (CDX) or nothing (blank).
Table 2
Use of the Quan/Qual analysis method to ﬁnd discriminative features in plasma of fed, fasted and/or cyclodextrin-dosed rats. Summary of the top 5 most discriminative
features identiﬁed by PLS-DA. This top 5 is based on the features with an ANOVA p-value > 0.05 upon comparison between plasma samples of fasted (F, n¼ 3) and fed (SD,
standard diet, n¼ 3) rats, dosed with either cyclodextrin (CDX, n¼ 3) or nothing (BLK, blank, n¼ 3).
Feature Average raw peak area (n¼ 3) (Coefﬁcient of Variation) Proposed identity
Observed m/z TR (min) F blank F CDX SD blank SD CDX Name m/z ppm error
1 260.1861 0.75 2.3Eþ05
(14%)
1.8Eþ05
(26%)
9.7Eþ04
(22%)
6.2Eþ04
(4%)
hexanoylcarnitine 260.1856 1
2 288.2171 1.07 7.9Eþ04
(9%)
6.5Eþ04
(28%)
3.8Eþ04
(19%)
2.6Eþ04
(8%)
octanoylcarnitine 288.2169 0
3 384.2743 1.43 3.0Eþ04
(8%)
2.4Eþ04
(32%)
1.1Eþ04
(21%)
8.0Eþ03
(8%)
Unknown Unknown Unknown
4 316.2491 1.35 7.3Eþ04
(12%)
5.9Eþ04
(27%)
3.5Eþ04
(20%)
2.4Eþ04
(6%)
decanoylcarnitine 316.2482 2
5 360.2728 1.39 1.8Eþ04
(4%)
1.4Eþ04
(35%)
7.0Eþ03
(9%)
5.4Eþ03
(25%)
Unknown Unknown Unknown
TR: Retention time.
A.-C. Dubbelman et al. / Analytica Chimica Acta 1020 (2018) 62e75 73tested analytes. In a drug metabolite application, applying 3D peak
detection in UNIFI software, these settings resulted in both parent
m/z values and fragmentation spectra for compound identiﬁcation
with limited loss of chromatographic resolution. Finally, in a non-
targeted metabolomics application, applying Progenesis QI for
peak detection, alignment over sample groups and integration,
these settings revealed several acylcarnitines as biologically rele-
vant metabolites to distinguish fasting from fed rats.
Since the above mentioned HRMS settings are optimized on aspeciﬁc (although widely applicable) UHPLC method and because
each Quan/Qual method can have its own (main) purpose we will
here recommend on the optimization of the mass spectrometric
parameters for future Quan/Qual method development.4.1. Mass resolution
The Synapt G2S mass spectrometer has three mass resolution
modes: high sensitivity, normal resolution and high resolution.
A.-C. Dubbelman et al. / Analytica Chimica Acta 1020 (2018) 62e7574Although the performance of each mode highly depends on in-
strument tuning, the high resolution mode is not recommended for
Quan/Qual analysis because of the extreme loss in sensitivity
inherent to the TOF-section of the instrument running in W-mode
instead of V-mode. The difference between the high sensitivity and
normal resolution modes in terms of signal-to-noise ratio, mass
resolution and ﬁle size were not found to be signiﬁcant in this
study, making both modes evenly applicable for Quan/Qual anal-
ysis. Contrary toToF-based high-resolutionmass spectrometers like
the tested Synapt G2S, Orbitrap-based MS systems show an inverse
relation between scan time and mass resolution. For high-
throughput Quan/Qual applications with narrow UPLC peaks, this
means that the mass resolution should be optimized to prevent
compromising the chromatographic resolution.
4.2. Scan mode
The scan mode selection should be based on the objective of the
Quan/Qual method. The TOF-MS, MSE and HDMSE scan modes,
respectively, provide an increasing amount of qualitative informa-
tion. Their quantitative performance in terms of accuracy, precision
and linear dynamic range showed an opposite trend, although the
performance of the MSE mode came close to that in the TOF-MS
mode. For generic high-throughput Quan/Qual method develop-
ment the MSE mode would therefore be advised, but if the focus is
more on the qualitative aspect of the method then HDMSE could
give some extra information.
4.3. Scan time
The present study showed with several examples how the scan
time can affect the chromatographic resolution. If the scan time is
too long, the number of data points across the chromatographic
peak is insufﬁcient to adequately describe it, which, especially after
smoothing, results in a lower chromatographic resolution. Scan
time should therefore be adapted to the peak width. The presented
Quan/Qual MSE method with 30ms scan time and peaks of around
11 data points shows that the common standards of a scan time of
at least 100ms and at least 15e20 data points per peak can be
pushed.
4.4. Smoothing
Also the amount of smoothing was demonstrated to impact the
chromatographic resolution. It is advised to apply a smoothing
factor to increase the signal-to-noise ratio, but to keep it as low as
possible to prevent peak broadening and masking of partially
resolved peaks.
4.5. Software
Only using UNIFI software sounds attractive for Quan/Qual
analysis as it can do both targeted quantitative and non-targeted
qualitative analysis and can use all dimensions of the collected
data (retention time, m/z, drift time and intensity) to precisely
detect peaks. While this software was indeed found to be very
useful for drug metabolite proﬁling and processing of ion mobility
enabled analyses, we considered other software packages more
user-friendly for other speciﬁc tasks. It must be mentioned how-
ever that UNIFI software is still continuously being further devel-
oped, to optimize e.g. speed, capabilities and user-friendliness.
Targetlynx can perform fast targeted quantitative analysis, which is
whywe, at least for now, recommend using this software unless the
drift time is crucial to separate the target compounds. For non-
targeted comparison of sample groups, Progenesis QI softwarewas found to be very intuitive and much faster when compared to
UNIFI.
4.6. Other recommendations
One of the observations in e.g. the application of the developed
Quan/Qual method on the rat plasma samples was the major in-
ﬂuence of matrix effect on the quantiﬁcation of targeted and non-
targeted compounds. For targeted quantitative analysis, stable
isotope labeled internal standards can correct well for the quanti-
ﬁcation of the target, but for non-targeted analysis more sophisti-
cated approaches may be required to limit or correct for matrix
effects [23]. This should be a point of consideration in future Quan/
Qual study design.
In summary, this paper describes the possibilities and limita-
tions of UHPLC-HRMS Quan/Qual analysis. In addition, it provides
both a ready-to-use accurate, precise and sensitive high-
throughput Quan/Qual UHPLC-MSE method, widely applicable in
e.g. drug metabolism and (pharmaco)metabolomics studies, and
recommendations on the development of future Quan/Qual
methods.
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